Work

Employment History of Lin Zhao

Amgen

Executive Scientific Director , Rare Disease Clinical Development

Horizon

Senior Scientific Director, Clinical Development

Astellas Pharma

Director Immunology, Clinical Pharmacology and Experimental Development

Takeda Pharmaceuticals

Associate Director and Fellow, Clinical Science, Cardiovascular and Metabolic Disease

TAP Pharmaceutical Products Inc.

Associate Director, Scientific Affair

Abbott

Pharmacologist, Department of Immunological Disease Research, PPD

RIBI ImmunoChem Research Inc (now part of GSK)

Research Scientist, Pharmacology Laboratory Manager

TAP Pharmaceuticals

Associate Director, Scientific Affair

Horizon Pharma, Inc.

Executive Scientific Director, Clinical Development

Schools

Schools Attended by Lin Zhao

  • China Pharmaceutical University
  • University of Montana

Related

Others that have worked at the same companies

Responsible Person, Benelux Quality Assurance at astellas.com
Sr. Research Investigator, Medicinal Chemistry and Manager of OSI Chemistry Outsourcing at astellas.com
Executive Director, Global Regulatory Affairs, Operations, Labeling and Technology Execution at astellas.com

Vice President, Head of Clinical Development at disabled.takeda.com
Assistant Director at disabled.takeda.com

Chief Executive Officer at takeda.com
Thought Leader Liaison, GI at takeda.com
Executive Sales Specialist at takeda.com

Frequently Asked Questions

Lin Zhao is a Executive Scientific Director , Rare Disease Clinical Development at Amgen located in Chicago, IL.

Lin Zhao works as a Executive Scientific Director , Rare Disease Clinical Development at Amgen.

Lin Zhao is located in Chicago, IL.

Lin Zhao attended China Pharmaceutical University, University of Montana.

Lin Zhao has worked with colleagues at various companies. You can see some of their coworkers listed above who have worked at the same organizations.

You can send Lin Zhao a message using the contact form on this page, or click "Show Contact Info" to view additional contact details.